Libros con envío 1 día | Envío GRATIS* a Península por tiempo limitado +  ¡Ver más!

menú

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials (Chapman & Hall (en Inglés)
Formato
Libro Físico
Editorial
Idioma
Inglés
N° páginas
376
Encuadernación
Tapa Blanda
ISBN13
9781032093505
N° edición
1

Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials (Chapman & Hall (en Inglés)

Mark Chang; John Balser; Jim Roach; Robin Bliss (Autor) · Routledge · Tapa Blanda

Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials (Chapman & Hall (en Inglés) - Mark Chang; John Balser; Jim Roach; Robin Bliss

Libro Nuevo

54,39 €

57,26 €

Ahorras: 2,86 €

5% descuento
  • Estado: Nuevo
  • Quedan 10 unidades
Origen: Estados Unidos (Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el Viernes 28 de Junio y el Viernes 19 de Julio.
Lo recibirás en cualquier lugar de España entre 1 y 5 días hábiles luego del envío.

Reseña del libro "Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials (Chapman & Hall (en Inglés)"

"This is truly an outstanding book. [It] brings together all of the latest research in clinical trials methodology and how it can be applied to drug development.... Chang et al provide applications to industry-supported trials. This will allow statisticians in the industry community to take these methods seriously." Jay Herson, Johns Hopkins UniversityThe pharmaceutical industry's approach to drug discovery and development has rapidly transformed in the last decade from the more traditional Research and Development (R & D) approach to a more innovative approach in which strategies are employed to compress and optimize the clinical development plan and associated timelines. However, these strategies are generally being considered on an individual trial basis and not as part of a fully integrated overall development program. Such optimization at the trial level is somewhat near-sighted and does not ensure cost, time, or development efficiency of the overall program. This book seeks to address this imbalance by establishing a statistical framework for overall/global clinical development optimization and providing tactics and techniques to support such optimization, including clinical trial simulations. Provides a statistical framework for achieve global optimization in each phase of the drug development process. Describes specific techniques to support optimization including adaptive designs, precision medicine, survival-endpoints, dose finding and multiple testing. Gives practical approaches to handling missing data in clinical trials using SAS. Looks at key controversial issues from both a clinical and statistical perspective. Presents a generous number of case studies from multiple therapeutic areas that help motivate and illustrate the statistical methods introduced in the book. Puts great emphasis on software implementation of the statistical methods with multiple examples of software code (both SAS and R). It is important for statisticians to possess a deep knowledge of the drug development process beyond statistical considerations. For these reasons, this book incorporates both statistical and "clinical/medical" perspectives.

Opiniones del libro

Ver más opiniones de clientes
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Preguntas frecuentes sobre el libro

Todos los libros de nuestro catálogo son Originales.
El libro está escrito en Inglés.
La encuadernación de esta edición es Tapa Blanda.

Preguntas y respuestas sobre el libro

¿Tienes una pregunta sobre el libro? Inicia sesión para poder agregar tu propia pregunta.

Opiniones sobre Buscalibre

Ver más opiniones de clientes